# AveXis to build $55M gene therapy plant in Durham, North Carolina

AveXis, a Novartis company, is investing $55 million to build a new manufacturing facility in Durham, North Carolina, creating 200 jobs. The facility will produce gene therapy AVXS-101 for spinal muscular atrophy.

- Type: New facility
- Announced: 2018-05-23
- Where: Durham, North Carolina, United States
- Value: $55.0M
- Jobs: 200
- Status: announced
- Products: gene therapy AVXS-101
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [AveXis](https://endata.com/companies/32040.md)
- [Novartis](https://endata.com/companies/32041.md) (investor)
- [Novartis](https://endata.com/companies/32041.md) (partner)

## Sources

- [biospace.com](https://www.biospace.com/novartis-avexis-to-build-gene-therapy-factory-in-durham-north-carolina), 2018-05-23: "AveXis, a Novartis company based in Illinois, is investing $55 million to build a new manufacturing facility in Durham, North Carolina."
- [smanewstoday.com](https://smanewstoday.com/news/avexis-opening-new-manufacturing-center-north-carolina/), 2018-10-25: "We're proud to be the place where cutting edge work will happen on gene therapies to fight disease and improve people's health"

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.